Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Primers 2017;3:17013.
Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou P. Treatments for dysarthria in Parkinson's disease. Lancet Neurol 2004;3:547–556.
Sapir S, Ramig LO, Hoyt P, Countryman S, O'Brien C, Hoehn M. Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson's disease: a comparison with an alternative speech treatment. Folia Phoniatr Logop 2002;54:296–303.
Lechien JR, Blecic S, Huet K, et al. Voice quality outcomes of idiopathic Parkinson's disease medical treatment: a systematic review. Clin Otolaryngol 2018;43:882–903.
Terroba Chambi C, Rossi M, Bril A, et al. Diagnostic value of combined acute levodopa challenge and olfactory testing to predict Parkinson's disease. Mov Disord Clin Pract 2017;4:824–828.
Malek N, Kanavou S, Lawton MA, et al. L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression. Parkinsonism Relat Disord 2019;65:55–61.
D'Alatri L, Paludetti G, Contarino MF, Galla S, Marchese MR, Bentivoglio AR. Effects of bilateral subthalamic nucleus stimulation and medication on Parkinsonian speech impairment. J Voice 2008;22:365–372.
Jiang J, Lin E, Wang J, Hanson DG. Glottographic measures before and after levodopa treatment in Parkinson's disease. Laryngoscope 1999;109:1287–1294.
Sanabria J, Ruiz PG, Gutierrez R, et al. The effect of levodopa on vocal function in Parkinson's disease. Clin Neuropharmacol 2001;24:99–102.
Mate MA, Cobeta I, Jiménez-Jiménez FJ, Figueiras R. Digital voice analysis in patients with advanced Parkinson's disease undergoing deep brain stimulation therapy. J Voice 2012;26:496–501.
Ziemann U, Tergau F, Bruns D, Baudewig J, Paulus W. Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr Clin Neurophysiol 1997;105:430–437.
Zunhammer M, Gerardi M, Bingel U. The effect of dopamine on conditioned placebo analgesia in healthy individuals: a double-blind randomized trial. Psychopharmacology (Berl) 2018;235:2587–2595.
Györfi O, Nagy H, Bokor M, Kelemen O, Kéri S. A single dose of L-DOPA changes perceptual experiences and decreases latent inhibition in Parkinson's disease. J Neural Transm (Vienna) 2017;124:113–119.
Szewczyk-Krolikowski K, Tomlinson P, Nithi K, et al. The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism Relat Disord 2014;20:99–105.
Lechien JR, Blecic S, Ghosez Y, Huet K, Harmegnies B, Saussez S. Voice quality and orofacial strength as outcome of levodopa effectiveness in patients with early idiopathic Parkinson disease: a preliminary report. J Voice 2019;33:716–720.
Hirano M. Clinical Examination of Voice. New York, NY: Springer; 1981:56–64.
Lechien JR. Étude quantitative des variations de la qualité vocale: analyse à base acoustique des conséquences, sur le signal de parole, de trois types de pathologies ORL. Belgium: University of Mons; 2017.
Holmes RJ, Oates JM, Phyland DJ, Hughes AJ. Voice characteristics in the progression of Parkinson's disease. Int J Lang Commun Disord 2000;35:407–418.
Lechien JR, Huet K, Finck C, et al. Are the acoustic measurements reliable in the assessment of voice quality? A methodological prospective study. J Voice 2019;23:S0892-1997(19)30328-5. https://doi.org/10.1016/j.jvoice.2019.08.022.
Yücetürk AV, Yilmaz H, Eğrilmez M, Karaca S. Voice analysis and videolaryngostroboscopy in patients with Parkinson's disease. Eur Arch Otorhinolaryngol 2002;259:290–293.
Solomon NP, Clark HM, Makashay MJ, Newman LA. Assessment of orofacial strength in patients with dysarthria. J Med Speech Lang Pathol 2008;16:251–258.
Clark HM, Henson PA, Barber WD, Stierwalt JAS, Sherrill M. Relationships among subjective and objective measures of tongue strength and oral phase swallowing impairments. Am J Speech Lang Pathol 2003;12:40–50.
Lechien JR, Morsomme D, Finck C, et al. The effect of the speech task characteristics on perceptual judgment of mild to moderate dysphonia: a methodological study. Folia Phoniatr Logop 2018;70:156–164.
Goberman A, Coelho C, Robb M. Phonatory characteristics of Parkinsonian speech before and after morning medication: the ON and OFF states. J Commun Disord 2002;35:217–239.
Merello M, Nouzeilles MI, Arce GP, Leiguarda R. Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis. Mov Disord 2002;17:795–798.
